Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation
| Status: | Recruiting |
|---|---|
| Conditions: | Hematology |
| Therapuetic Areas: | Hematology |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 1/1/2014 |
| Start Date: | June 2011 |
| End Date: | December 2020 |
Reporting of Amyloidosis Stem Cell Transplantation Outcomes
This study examines the value of stem cell transplantation in managing light chain
amyloidisis.
amyloidisis.
1. How does age at diagnosis affect prognosis in primary amyloidosis?
2. How do lab values at diagnosis such as Creatinine, AST/ALT, total serum protein, serum
gamma globulin/immunoglobulin levels affect prognosis in primary amyloidosis?
3. How does degree of organ involvement/number of organs involved affect prognosis in
primary amyloidosis?
4. How does initial treatment affect prognosis in primary amyloidosis?
4. How do the specifics the stem cell transplant protocol affect prognosis in primary
amyloidosis?
2. How do lab values at diagnosis such as Creatinine, AST/ALT, total serum protein, serum
gamma globulin/immunoglobulin levels affect prognosis in primary amyloidosis?
3. How does degree of organ involvement/number of organs involved affect prognosis in
primary amyloidosis?
4. How does initial treatment affect prognosis in primary amyloidosis?
4. How do the specifics the stem cell transplant protocol affect prognosis in primary
amyloidosis?
Inclusion Criteria:
- Eligible for Stem cell transplantation less than age 75
Exclusion Criteria:
- Creatinine > 3.0
- BNP > 10000
We found this trial at
1
site
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
